A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve clinical outcomes. Now a study ...
Sep 16, 2014
2 / 5 (7) | 0
(Medical Xpress)—A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists.
Sep 05, 2014
5 / 5 (2) | 0